Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-10-14 Purchase | 2020-10-16 3:51 pm | Kronos Bio Inc. | KRON | MARTIN JOHN C Director | 75,800 | $19 | $1,440,200 | 1,952,364 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-03-03 Option Award | 2021-03-05 8:04 pm | 2022-03-03 2031-03-03 | Sarepta Therapeutics Inc. | SRPT | MARTIN JOHN C Director | 8,244 | $0 | 13,431 (Direct) | View |
| 2020-10-14 Conversion | 2020-10-16 3:51 pm | N/A N/A | Kronos Bio Inc. | KRON | MARTIN JOHN C Director | 6,570,443 | $0 | 1,952,364 (Indirect) | View |
| 2020-10-14 Conversion | 2020-10-16 3:51 pm | N/A N/A | Kronos Bio Inc. | KRON | MARTIN JOHN C Director | 205,260 | $16.15 | 1,952,364 (Indirect) | View |
Ownership | 2020-10-08 7:11 pm | N/A N/A | Kronos Bio Inc. | KRON | MARTIN JOHN C Director | 0 | $0 | 1,876,564 (Direct) | View |
| 2020-02-28 Option Award | 2020-02-28 8:02 pm | N/A 2020-02-28 | Sarepta Therapeutics Inc. | SRPT | MARTIN JOHN C Director | 14,400 | $0 | 14,400 (Direct) | View |